What to Expect After First Ozempic Shot: A Week 1 Guide

Last reviewed: July 6, 2026

Last updated: July 6, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

The first seven days after your initial semaglutide injection represent a critical adaptation window for your body. Clinical data shows that most patients begin experiencing appetite-suppressing effects within 24–48 hours, though the intensity varies based on individual metabolic factors and genetic predisposition. Understanding what happens in week one helps you distinguish normal adjustment from concerning reactions.

How Semaglutide Injection Works During Your First Week

Semaglutide activates GLP-1 receptors in your brain and digestive system, signaling fullness and reducing hunger signals. During the initial seven days, the medication concentrations in your bloodstream build gradually, triggering progressive changes in appetite regulation and food preferences. This gradual onset is intentional—it gives your body time to adjust rather than shocking your system with immediate, severe side effects.

Your starting dose is calculated to be therapeutic yet tolerable. PlexusDx patients receive compounded semaglutide from licensed 503A pharmacies, ensuring pharmaceutical-grade purity and consistency. The slow ramp during week one means most people experience mild to moderate appetite reduction rather than complete loss of desire to eat, making the transition more sustainable than higher initial doses.

Expected Appetite and Hunger Changes in Days 1–7

By day two or three, many patients report noticing that food feels less rewarding or urgent. Portion sizes that previously felt normal may suddenly feel excessive. Some describe foods they once craved as less appealing or even mildly unappealing. These psychological and sensory shifts often precede measurable changes in appetite hormone levels, reflecting semaglutide's multi-pathway action in the central nervous system.

Week one appetite suppression is typically mild compared to weeks two through four, when effects plateau at steady state. You may find yourself naturally eating 20–30% fewer calories without deliberate restriction, simply because satiation arrives sooner. This makes week one an ideal time to pay attention to your body's new signals and adjust portion habits before more pronounced appetite loss arrives.

Common Week 1 Side Effects and Management Strategies

Nausea is the most frequently reported week-one effect, typically beginning 12–36 hours after injection and often improving by day four or five. Nausea during semaglutide therapy usually feels different from illness—it's often mild, situational, and triggered by eating too quickly or consuming high-fat foods. Eating smaller meals, staying hydrated, and avoiding triggers like caffeine on an empty stomach help most patients manage nausea naturally without medication.

Constipation and mild fatigue may also emerge in days two through seven. These reflect your body adjusting to reduced food volume and changes in gut motility. Increasing water intake, adding fiber-rich foods if tolerated, and maintaining light physical activity support comfort without interventions. Most patients find that week-one side effects resolve or significantly diminish by day six or seven as their system stabilizes.

Why Your Genetic Profile Influences Your Week 1 Experience

Not everyone experiences week one identically. Variations in GLP-1 receptor genes, GIPR signaling, and appetite-regulating pathways influence how quickly semaglutide's effects emerge and which side effects dominate. The PlexusDx Precision Peptide Genetic Test maps 14 metabolic pathways across 49 peptides, identifying your genetic predispositions to appetite sensitivity, nausea tolerance, and medication efficacy.

Patients with certain MC4R or FTO variants, for example, may notice stronger appetite suppression in week one, while others with different GLP1R rs6923761 configurations might experience delayed appetite effects but more gastrointestinal adjustment. This genetic insight for $298, helps PlexusDx providers personalize your dose progression and anticipate individual response patterns, moving beyond one-size-fits-all protocols.

Practical Week 1 Habits to Support Your Adjustment

Timing your injection matters. Most patients benefit from injecting on the same day and time each week, either Friday evening or Sunday morning, aligning with their meal patterns. Eating a small, balanced meal 1–2 hours before your injection reduces nausea risk. Staying hydrated throughout the week—aiming for half your body weight in ounces of water daily—buffers dehydration and supports your kidneys as metabolism shifts.

Track how your hunger feels, not just what you eat. A simple log of appetite level (1–10 scale) at meals, energy levels, and any side effects helps you distinguish normal adjustment from individual patterns. By day seven, you'll have baseline data to share with your PlexusDx provider, enabling them to confidently adjust your dose at week four if needed. Remember: PlexusDx pricing stays flat regardless of dose changes—your dose may increase, but your monthly cost remains the same.

When to Contact Your PlexusDx Provider During Week One

Most week-one experiences fall within normal adjustment ranges. However, reach out to your PlexusDx team if severe vomiting persists beyond day three, you develop signs of dehydration (extreme thirst, dark urine, dizziness), or experience severe abdominal pain. These warrant evaluation to rule out rare complications or confirm you're responding safely to your dose.

Conversely, feeling nothing at all by day five is not necessarily a concern—some patients have delayed onset. Mild nausea or loose stools that don't impair function are expected and typically improve by week two. PlexusDx provides 24/7 support for all patients, with licensed providers available to answer questions and adjust expectations based on your individual trajectory.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Will I feel sick the entire first week after my semaglutide injection?

Nausea, if it occurs, typically begins 12–36 hours after injection and often resolves by day four or five. Most patients experience mild, situational nausea rather than constant sickness, and eating smaller, lower-fat meals significantly reduces symptom severity. By day six or seven, the majority of PlexusDx patients report feeling normal or near-normal.

How much weight will I lose in week one of semaglutide therapy?

Weight loss in week one is usually minimal—often just 0–3 pounds, primarily water weight reflecting reduced food volume and glycogen depletion. Meaningful fat loss begins in week two through four as appetite suppression deepens and calorie deficit compounds. Expecting gradual, consistent week-to-week progress rather than rapid initial loss supports long-term sustainability.

Can I eat normally during my first week on semaglutide injection?

You can eat solid foods immediately after injection, though many patients naturally eat less because of emerging appetite suppression. Eating slowly, chewing thoroughly, and stopping when comfortably full prevents nausea and overfilling your stomach. By day three or four, most people find that their portion sizes self-correct without conscious restriction.

What does PlexusDx semaglutide cost, and does pricing change if my dose increases?

PlexusDx compounded semaglutide injection is $189/mo month-to-month (or $149/mo on the 6-month plan) and remains flat across all dose levels—your dose may increase, but your price won't. No insurance or membership is required, and treatment is HSA/FSA eligible. This transparent, non-flat per-compound pricing removes the financial barrier to safe dose titration.

How does the Precision Peptide Genetic Test relate to your GLP-1 pathway?

No — the Precision Peptide Genetic Test does not predict your response to Ozempic or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Ozempic Shot
• Low Histamine Diet Week 1
• Maximus Glp 1
• Lifemd Ozempic

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.